BBIO logo

BridgeBio Pharma, Inc. (BBIO) CAPEX

annual CAPEX:

$8.91M+$7.60M(+582.08%)
December 31, 2024

Summary

  • As of today (September 14, 2025), BBIO annual capital expenditures is $8.91 million, with the most recent change of +$7.60 million (+582.08%) on December 31, 2024.
  • During the last 3 years, BBIO annual CAPEX has fallen by -$39.34 million (-81.54%).
  • BBIO annual CAPEX is now -81.54% below its all-time high of $48.25 million, reached on December 31, 2021.

Performance

BBIO CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

quarterly CAPEX:

$5.09M+$3.50M(+219.37%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BBIO quarterly capital expenditures is $5.09 million, with the most recent change of +$3.50 million (+219.37%) on June 30, 2025.
  • Over the past year, BBIO quarterly CAPEX has increased by +$2.65 million (+108.17%).
  • BBIO quarterly CAPEX is now -87.71% below its all-time high of $41.46 million, reached on September 30, 2021.

Performance

BBIO quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

TTM CAPEX:

$11.66M+$2.65M(+29.38%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BBIO TTM capital expenditures is $11.66 million, with the most recent change of +$2.65 million (+29.38%) on June 30, 2025.
  • Over the past year, BBIO TTM CAPEX has increased by +$6.85 million (+142.62%).
  • BBIO TTM CAPEX is now -76.09% below its all-time high of $48.76 million, reached on June 30, 2022.

Performance

BBIO TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

BBIO CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+582.1%+108.2%+142.6%
3 y3 years-81.5%+30.6%-76.1%
5 y5 years+73.4%+1372.3%+67.7%

BBIO CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.5%+582.1%at high>+9999.0%-76.1%+792.6%
5 y5-year-81.5%+582.1%-87.7%>+9999.0%-76.1%+792.6%
alltimeall time-81.5%+1819.8%-87.7%>+9999.0%-76.1%+792.6%

BBIO CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$5.09M(+219.4%)
$11.66M(+29.4%)
Mar 2025
-
$1.59M(-50.7%)
$9.01M(+1.2%)
Dec 2024
$8.91M(+582.1%)
$3.24M(+86.9%)
$8.91M(+45.9%)
Sep 2024
-
$1.73M(-29.2%)
$6.11M(+27.1%)
Jun 2024
-
$2.45M(+64.0%)
$4.80M(+72.5%)
Mar 2024
-
$1.49M(+243.0%)
$2.79M(+113.3%)
Dec 2023
$1.31M(-79.3%)
$435.00K(+0.9%)
$1.31M(-21.9%)
Sep 2023
-
$431.00K(+0.7%)
$1.67M(-16.4%)
Jun 2023
-
$428.00K(+3466.7%)
$2.00M(-63.5%)
Mar 2023
-
$12.00K(-98.5%)
$5.47M(-13.4%)
Dec 2022
$6.32M(-86.9%)
$801.00K(+5.5%)
$6.32M(-21.5%)
Sep 2022
-
$759.00K(-80.5%)
$8.06M(-83.5%)
Jun 2022
-
$3.90M(+354.2%)
$48.76M(+3.4%)
Mar 2022
-
$859.00K(-66.1%)
$47.14M(-2.3%)
Dec 2021
$48.25M
$2.54M(-93.9%)
$48.25M(+0.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
$41.46M(+1712.9%)
$47.86M(+589.3%)
Jun 2021
-
$2.29M(+16.6%)
$6.94M(+38.8%)
Mar 2021
-
$1.96M(-8.6%)
$5.00M(-33.5%)
Dec 2020
$7.52M(+46.3%)
$2.15M(+290.9%)
$7.52M(+5.6%)
Sep 2020
-
$549.00K(+58.7%)
$7.12M(+2.4%)
Jun 2020
-
$346.00K(-92.3%)
$6.95M(-3.3%)
Mar 2020
-
$4.48M(+156.3%)
$7.19M(+39.9%)
Dec 2019
$5.14M(-71.7%)
$1.75M(+358.5%)
$5.14M(+51.5%)
Sep 2019
-
$381.00K(-34.6%)
$3.39M(-6.2%)
Jun 2019
-
$583.00K(-76.0%)
$3.62M(-22.9%)
Mar 2019
-
$2.43M(+301.2%)
$4.69M(-73.1%)
Dec 2018
$18.18M(+3817.7%)
-
-
Sep 2018
-
$605.00K(-63.4%)
$17.44M(+3.6%)
Jun 2018
-
$1.66M(-89.1%)
$16.83M(+10.9%)
Mar 2018
-
$15.18M
$15.18M
Dec 2017
$464.00K
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual CAPEX year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly CAPEX year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM CAPEX year-on-year change?

What is BridgeBio Pharma, Inc. annual capital expenditures?

The current annual CAPEX of BBIO is $8.91M

What is the all time high annual CAPEX for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual capital expenditures is $48.25M

What is BridgeBio Pharma, Inc. annual CAPEX year-on-year change?

Over the past year, BBIO annual capital expenditures has changed by +$7.60M (+582.08%)

What is BridgeBio Pharma, Inc. quarterly capital expenditures?

The current quarterly CAPEX of BBIO is $5.09M

What is the all time high quarterly CAPEX for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly capital expenditures is $41.46M

What is BridgeBio Pharma, Inc. quarterly CAPEX year-on-year change?

Over the past year, BBIO quarterly capital expenditures has changed by +$2.65M (+108.17%)

What is BridgeBio Pharma, Inc. TTM capital expenditures?

The current TTM CAPEX of BBIO is $11.66M

What is the all time high TTM CAPEX for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM capital expenditures is $48.76M

What is BridgeBio Pharma, Inc. TTM CAPEX year-on-year change?

Over the past year, BBIO TTM capital expenditures has changed by +$6.85M (+142.62%)
On this page